Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Vaccine pharmacotherapy for the treatment of cocaine dependence.

Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR.

Biol Psychiatry. 2005 Jul 15;58(2):158-64.

PMID:
16038686
2.

Human therapeutic cocaine vaccine: safety and immunogenicity.

Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Jack L, Fox B.

Vaccine. 2002 Jan 15;20(7-8):1196-204.

PMID:
11803082
3.

Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans.

Haney M, Gunderson EW, Jiang H, Collins ED, Foltin RW.

Biol Psychiatry. 2010 Jan 1;67(1):59-65. doi: 10.1016/j.biopsych.2009.08.031.

4.

Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.

Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K.

Drug Alcohol Depend. 2014 Jul 1;140:42-7. doi: 10.1016/j.drugalcdep.2014.04.003. Epub 2014 Apr 16.

5.

Therapeutic vaccines for substance dependence.

Kosten TR, Biegel D.

Expert Rev Vaccines. 2002 Oct;1(3):363-71. Review.

PMID:
12901575
6.

Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.

Olivier C, Belohradsky BH, Stojanov S, Bonnet E, Petersen G, Liese JG.

Vaccine. 2008 Jun 13;26(25):3142-52. doi: 10.1016/j.vaccine.2007.11.096. Epub 2008 May 6.

PMID:
18502545
7.
8.

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.

Bernstein DI, Edwards KM, Dekker CL, Belshe R, Talbot HK, Graham IL, Noah DL, He F, Hill H.

J Infect Dis. 2008 Mar 1;197(5):667-75. doi: 10.1086/527489.

PMID:
18260764
9.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
10.

Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease.

Aziz A, Aziz S, Li DS, Murphy L, Leone N, Kennedy M, Dhillon S, Van Thiel DH.

J Viral Hepat. 2006 Apr;13(4):217-21.

PMID:
16611186
11.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
12.

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.

Künzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kürsteiner O, Kompier R, Grimaldi R, Goudsmit J.

Vaccine. 2009 Jun 2;27(27):3561-7. doi: 10.1016/j.vaccine.2009.03.062. Epub 2009 Apr 10.

PMID:
19464535
13.

Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults.

Aguilar-Betancourt A, González-Delgado CA, Cinza-Estévez Z, Martínez-Cabrera J, Véliz-Ríos G, Alemán-Zaldívar R, Alonso-Martínez MI, Lago-Baños M, Puble-Alvarez N, Delahanty-Fernandez A, Juvier-Madrazo AI, Ortega-León D, Olivera-Ruano L, Correa-Fernández A, Abreu-Reyes D, Soto-Mestre E, Pérez-Pérez MV, Figueroa-Baile N, Pérez LH, Rodríguez-Silva A, Martínez-Díaz E, Guillén-Nieto GE, Muzio-González VL.

Hum Vaccin. 2008 Jan-Feb;4(1):54-9. Epub 2007 Aug 31.

PMID:
18441530
14.

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial.

Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR.

Arch Gen Psychiatry. 2009 Oct;66(10):1116-23. doi: 10.1001/archgenpsychiatry.2009.128.

15.

The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial.

Wagena EJ, de Vos A, Horwith G, van Schayck CP.

Nicotine Tob Res. 2008 Jan;10(1):213-8. doi: 10.1080/14622200701704921.

PMID:
18188762
17.

Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.

Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.

Vaccine. 2006 Mar 10;24(11):1776-85. Epub 2005 Oct 27.

PMID:
16303216
18.

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.

Kündig TM, Senti G, Schnetzler G, Wolf C, Prinz Vavricka BM, Fulurija A, Hennecke F, Sladko K, Jennings GT, Bachmann MF.

J Allergy Clin Immunol. 2006 Jun;117(6):1470-6. Epub 2006 Apr 27.

PMID:
16751015
20.

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.

Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y.

Vaccine. 2009 Jan 14;27(3):454-9. doi: 10.1016/j.vaccine.2008.10.077. Epub 2008 Nov 18.

PMID:
19022318

Supplemental Content

Support Center